MedTrace Logo

The Prevention of Failure to Rescue Using Early Warning Scoring

NCT01197326 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 414

Last updated 2016-05-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess if, compared with standard paper-based systems, an automated Early Warning System (EWS) resident in a spot check patient monitor, can help to identify deteriorating patients.

Conditions

  • Sepsis
  • Renal Failure
  • Pulmonary Edema
  • Cardio-pulmonary Arrest

Interventions

DEVICE

use of the MP5 EWS patient monitor

All patients on the study ward receive the same care in Groups 1 and 2. The only difference is the device used to collect the vital signs. In Group 2, the MP5 EWS spot check monitor (FDA approved and CE marked) is the vital signs collection device.

Sponsors & Collaborators

  • Philips Healthcare

    lead INDUSTRY

Principal Investigators

  • Rinaldo Bellomo, MD · Faculty of Medicine, University of Melbourne, Melbourne, Australia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-05-31
Completion
2010-06-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01197326 on ClinicalTrials.gov